Pfizer to help Western Oncolytics move gene therapy through Phase I trials

Story excerpt provided by Crain’s Cleveland Business.

Written by Chuck Soder.

Pfizer plans to help Western Oncolytics move its gene therapy through Phase I clinical trials — and it could buy the company if those trials go well.

Under the agreement, Pfizer will work with the small Westlake-based company to complete animal trials and Phase I clinical trials. Afterward it would have the exclusive option to acquire the drug, according to a news release from the two companies.

The drug, which is called WO-12, is designed to fight cancer in multiple ways.

Click here to read the complete article.

Originally published July 28, 2016.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: